2026-05-11
Added · Updated
The Capital Markets Tribunal approved settlement agreements requiring Stan Bharti and Neil Said to pay a combined $985,000 in administrative penalties and $1.779 million in disgorgement, plus nearly $100,000 in costs, for authorizing material misstatements in Medivolve Inc.'s financial disclosures. Mr. Said is prohibited from acting as a director or officer of any issuer for five years, while Mr. Bharti is permanently banned from such roles. The penalties address their failure to disclose that they received shares from a 2020 acquisition of Amino Therapeutics Inc. and to report the transaction as a related-party deal.
More like this from OSC
OSC published 8 documents in the last 30 days. We email you each new one the day it's published.